Department of Cardio-Vascular and Thoracic Surgery, Örebro University Hospital, Örebro, Sweden.
J Endovasc Ther. 2012 Apr;19(2):144-8. doi: 10.1583/11-3699.1.
To describe our experience with a novel technique to decompress abdominal compartment syndrome after endovascular aneurysm repair (EVAR) of ruptured abdominal aortic aneurysm (rAAA).
From January 2003 to April 2010, 13 patients (12 men; mean age 75 years) treated for rAAA with EVAR underwent tissue plasminogen activator (tPA)-assisted decompression for intra-abdominal hypertension. All of the patients but one had intra-abdominal pressure >20 mmHg, with signs of multiple organ failure or abdominal perfusion pressure <60 mmHg. With computed tomography guidance, a drain was inserted into the retroperitoneal hematoma, and tPA solution was injected to facilitate evacuation of the coagulated hematoma and decrease the abdominal pressure.
In the 13 patients, the mean intra-abdominal pressure decreased from 23.5 mmHg (range 12-35) to 16 mmHg (range 10-28.5). A mean 1520 mL (range 170-2900) of blood was evacuated. Urine production (mean 130 mL/h, range 50-270) increased in 7 patients at 24 hours after tPA-assisted decompression; among the 5 patients in which urine output did not increase, 3 underwent hemodialysis by the 30-day follow-up. One patient did not respond with clinical improvement and required laparotomy. The 30-day, 90-day, and 1-year mortality was 38% (5/13 patients); none of the deaths was related to the decompression technique.
tPA-assisted decompression of abdominal compartment syndrome after EVAR can decrease the intra-abdominal pressure and could be useful in preventing multiple organ failure. It is a minimally invasive technique that can be used in selected cases but does not replace laparotomy or retroperitoneal surgical procedures as the gold standard treatments.
描述我们在血管内动脉瘤修复(EVAR)治疗破裂腹主动脉瘤(rAAA)后使用一种新的技术来治疗腹腔间隔室综合征(ACS)的经验。
2003 年 1 月至 2010 年 4 月,13 例接受 EVAR 治疗 rAAA 的患者(12 例男性;平均年龄 75 岁)因腹腔内高压而行组织型纤溶酶原激活物(tPA)辅助减压。所有患者除 1 例外,腹腔内压力均>20mmHg,存在多器官功能衰竭或腹主动脉灌注压<60mmHg 的迹象。在 CT 引导下,将引流管插入腹膜后血肿,注入 tPA 溶液,以促进凝固血肿的清除并降低腹内压。
在 13 例患者中,平均腹腔内压力从 23.5mmHg(范围 12-35mmHg)降至 16mmHg(范围 10-28.5mmHg)。平均排出 1520ml(范围 170-2900ml)血液。在 tPA 辅助减压后 24 小时,7 例患者的尿量(平均 130ml/h,范围 50-270ml/h)增加;5 例尿量未增加的患者中,3 例在 30 天随访时行血液透析。1 例患者临床改善不明显,需行剖腹手术。30 天、90 天和 1 年死亡率分别为 38%(13 例患者中有 5 例);无死亡与减压技术相关。
EVAR 后 tPA 辅助治疗腹腔间隔室综合征可降低腹腔内压力,有助于预防多器官功能衰竭。这是一种微创技术,可用于选择病例,但不能替代剖腹手术或腹膜后手术作为金标准治疗。